Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of cultured allogeneic adult umbilical cord–derived mesenchymal stem cells for pulmonary diseases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Pulmonary Disease

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Pulmonary Disease, Asthma | Phase 1 | Status: RECRUITING